Easy access to new heterocyclic systems: 1,4-Oxazine and substituted 1,4-oxazines

Journal of Organic Chemistry

Volumn 72, Issue 13, 2007, Pages 4832-4836

  Claveau, Elise ^a   Gillaizeau, Isabelle ^a   Blu, Jérome ^a   Bruel, Amélie ^a   Coudert, Gérard ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS-COUPLING REACTIONS; HETEROCYCLIC DERIVATIVES; OXAZINE;

CATALYSIS; DERIVATIVES; NEGATIVE IONS; PALLADIUM; PHOSPHATES; SUBSTITUTION REACTIONS;

NITROGEN COMPOUNDS;

1,4 OXAZINE DERIVATIVE; BISVINYLPHOSPHATE 3; HETEROCYCLIC COMPOUND; MORPHOLINE 3,5 DIONE; MORPHOLINE DERIVATIVE; NITROGEN DERIVATIVE; PALLADIUM; PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL REACTION; REDUCTION; STILLE REACTION; SUZUKI REACTION; SYNTHESIS;

CATALYSIS; MOLECULAR STRUCTURE; OXAZINES; PHOSPHONIC ACIDS; VINYL COMPOUNDS;

EID: 34250821664     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo070528n     Document Type: Article

References (48)

1. (a) For diversity-oriented synthesis, see: Tan, D. S. Nat. Chem. Biol. 2005, 1, 74.
2. (b) Burke, M. D.; Schreiber, S. L. Angew. Chem., Int. Ed. 2004, 43, 46.
3. (c) Schreiber, S. L. Science 2000, 287, 1964.
4. (a) Lepifre, F.; Buon, C; Roger, P.-Y.; Bouyssou, P.; Coudert, G. Tetrahedron Lett. 2004, 45, 8257.
5. (b) Lepifre, F.; Clavier, S.; Bouyssou, P.; Coudert, G. Tetrahedron 2001, 57, 6969.
6. (c) Buon, C.; Chacun-Lefevre, L.; Rabot, R.; Bouyssou, P.; Coudert, G. Tetrahedron 2000, 56, 605.
7. (d) Lepifre, F.; Buon, C.; Rabot, R.; Bouyssou, P.; Coudert, G. Tetrahedron Lett. 1999, 40, 6373.
8. For a recent review on biologically active 1,4-benzoxazine derivatives, see the following: (a) Achari, B.; Mandal, S. B.; Dutta, P. K.; Chowdhury, C. Synlett 2004, 2449 and references therein.
9. For some recent examples, see also the following: (b) Rybczynski, P. J.; Zeck, R. E.; Dudash, J.; Combs, D. W.; Burris, T. P.; Yang, M.; Osborne, M. C.; Chen, X.; Demarest, K. T. J. Med. Chem. 2004, 47, 196.
10. (c) Yang, W.; Wang, Y.; Ma, Z.; Golla, R.; Stouch, T.; Seethala, R.; Johnson, S.; Zhou, R.; Güngör, T.; Feyen, J. H. M.; Dickson, J. K. Bioorg. Med. Chem. Lett. 2004, 14, 2327.
11. (d) Thomas, A.; Ross, R. A.; Saha, B.; Mahadevan, A.; Razdan, R. K.; Pertwee, R. G. Eur. J. Pharmacol. 2004, 487, 213.
12. (e) Caliendo, G.; Perissutti, E.; Santagada, V.; Fiorino, F.; Severino, B.; Cirillo, D.; d'Emmanuele di Villa Bianca, R.; Lippolis, L.; Pinto, A.; Sorrentino, R. Eur. J. Med. Chem. 2004, 39, 815.
13. (f) Dougherty, K. J.; Bannatyne, B. A.; Jankowska, E.; Krutki, P.; Maxwell, D. J. J. Neurosci. 2005, 25, 584.
14. (g) Stefanic Anderluh, P.; Anderluh, M.; Ilas, J.; Mravljak, J.; Sollner Dolenc, M.; Stegnar, M.; Kikelj, D. J. Med. Chem. 2005, 48, 3110.
15. (h) Lee, H. J.; Ban, J. Y.; Seong, Y. H. Life Sci. 2005, 78, 294.
16. (i) Xu, D.; Chiaroni, A.; Fleury, M.-B.; Largeron, M. J. Org. Chem. 2006, 71, 6374.
17. The sole literature precedent: Herbert, B. Arch. Pharm. 1982, 315, 684.
18. (a) Mousset, D.; Gillaizeau, I.; Hassan, J.; Lepifre, F.; Bouyssou, P.; Coudert, G. Tetrahedron Lett. 2005, 46, 3703.
19. (b) Mousset, D.; Gillaizeau, I.; Sabatié, A.; Bouyssou, P.; Coudert, G. J. Org. Chem. 2006, 71, 5993.
20. (a) Nicolaou, K. C.; Shi, G. Q.; Namoto, K.; Bernal, F. Chem. Commun. 1998, 1757.
21. (b) Nicolaou, K. C.; Shi, G. Q.; Gunzner, J. L.; Gärtner, P.; Yang, Z. J. Am. Chem. Soc. 1997, 119, 5467.
22. (c) Huffman, M. A.; Yasuda, N. Synlett 1999, 471.
23. (d) Jiang, J. L.; Devita, R. J.; Doss, G. A.; Goulet, M. T.; Wyvratt, M. J. J. Am. Chem. Soc. 1999, 121, 593.
24. (e) Moraes, D. N.; Barrientos-Astigarraga, R. E.; Castelani, P.; Comasseto, J. V. Tetrahedron 2000, 56, 3327.
25. (f) Coe, J. W. Org. Lett. 2000, 2, 4205.
26. (g) Wu, J.; Yang, Z. J. Org. Chem. 2001, 66, 7875.
27. (h) Sasaki, M.; Ishikawa, M.; Fuwa, H.; Tachibana, K. Tetrahedron 2002, 58, 1889.
28. (i) Miller, J. A. Tetrahedron Lett. 2002, 43, 7111.
29. (j) Takakura, H.; Sasaki, M.; Honda, S.; Tachibana, K. Org. Lett. 2002, 4, 2771.
30. (k) Lo Galbo, F.; Occhiato, E. G.; Guarna, A.; Faggi, C. J. Org. Chem. 2003, 68, 6360.
31. (l) Liao, Y.; Hu, Y. H.; Wu, H.; Zhu, Q.; Donovan, M.; Fathi, R.; Yang, Z. Curr. Med. Chem. 2003, 10, 2285.
32. (m) Campbell, I. B.; Guo, J.; Jones, E.; Steel, P. G. Org. Biomol. Chem. 2004, 2, 2725.
33. (n) Larsen, U. S.; Martiny, L.; Begtrup, M. Tetrahedron Lett. 2005, 46, 4261.
34. (o) Other research in this field: Occhiato, E.G.; Lo Galbo, F.; Guarna, A. J. Org. Chem. 2005, 70, 7324 and references cited therein.
35. (a) Klose, J.; Reese, C. B.; Song, Q. Tetrahedron 1997, 53, 14411.
36. (b) Wolfe, J. F.; Rogers, T. G. J. Org. Chem. 1970, 35, 3600.
37. The bisvinylphosphate 3 is stable for several months at 4°C under argon atmosphere.
38. (a) Watanabe, T.; Miyaura, N.; Suzuki, A. Synlett 1992, 207.
39. (b) Baudoin, O.; Guénard, D.; Guéritte, F. J. Org. Chem. 2000, 65, 9268.
40. Scott, W. J.; Stille, J. K. J. Am. Chem. Soc. 1986, 108, 3033.
41. Cacchi, S.; Morera, E.; Ortar, G. Tetrahedron Lett. 1984, 25, 4821.
42. Addition of HMPA, which stabilizes the formed anion, was in most cases useful to improve the reaction's yield.
43. (a) Sonogashira, K. In Metal-Catalyzed Cross-Coupling Reactions; Diederich, F., Stang, P. J., Eds.; Wiley-VCH: New York, 1998; Chapter 5.
44. (b) Brandsma, L.; Vasilevsky, S. F.; Verkruijsse, H. D. Application of Transition Metal Catalysts in Organic Synthesis; Springer-Verlag: Berlin, Germany, 1998; Chapter 10.
45. (c) Rossi, R.; Carpita, A.; Bellina, F. Org. Prep. Proced. Int. 1995, 27, 127.
46. (d) Sonogashira, K. In Comprehensive Organic Synthesis; Trost, B. M., Ed.; Pergamon: New York, 1991; Vol. 3, Chapter 2.4.
47. In the case of compounds 6c and 6k, only 1.5 equiv of n-BuLi (instead of 2 equiv) was used in order to preclude the reaction of the base directly on the 3,4,5-trimethoxyaldehyde. The obtained corresponding alcohol is difficult to separate effectively from the desired trisubstituted compound.
48. The regioselective functionalization of the oxazine 5 at the C-3 position was confirmed by the following reaction. The analytical data of compound 11 are depicted in the Experimental Section. (Chemical Equation Presented)